Research
Hormonal
Tirzepatide produces superior weight loss and glycemic control compared to GLP-1 receptor agonists (e.g., semaglutide) by acting as a balanced dual GIP/GLP-1 receptor agonist, leveraging GIP-mediated effects on adipose tissue metabolism and insulin sensitivity.
Tirzepatide is a once-weekly injectable medication that targets both GLP-1 and GIP receptors. It has been shown to produce significant weight loss (up to 25% in some trials) and improve blood sugar control, often outperforming GLP-1-only drugs. It is prescribed for obesity and type 2 diabetes under medical supervision.
StrongSupportsVERY_HIGH confidence
Tirzepatide, a dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, has demonstrated remarkable effectiveness in lowering glucose levels and reducing weight in the SURPASS and SURMOUNT trials... tirzepatide (Zepbound)가 GLP-1수용체에만 특이적으로 작용하는 semaglutide 1.0 mg에 비해 체중감량의 정도가 우월한 결과를 보인 바 있다.
Why this rating
Supported by multiple high-impact clinical trials (SURPASS, SURMOUNT) and preclinical studies cited.
Source
GLP-1/GIP Receptor Agonists: Mechanism of Action of Tirzepatide
Tae Jung Oh · Journal of Korean Diabetes · 2024
DOI 10.4093/jkd.2024.25.2.76
narrative_reviewCited 2×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →